[1]
“Respiratory infections by Achromobacter xylosoxidans in a cohort of Cystic Fibrosis patients: identification, antimicrobial susceptibility and molecular epidemiology”, Microbiol Med, vol. 25, no. 1, Mar. 2010, doi: 10.4081/mm.2010.2486.